Full text is available at the source.
Abstract
Lipid nanoparticles (LNPs) made with the sulfoxide polymer PMSEA show superior transfection efficiency compared to traditional PEG-based formulations.
- PMSEA-DSPE conjugates were developed to improve the stability and immunogenicity of LNPs for mRNA delivery.
- These new LNPs exhibited excellent stability and low immunogenicity, which are beneficial for mRNA therapeutics.
- PMSEA-LNP formulations demonstrated higher transfection efficiency than PEG-based LNPs in preliminary evaluations.
- The findings suggest that PMSEA could be a promising alternative for enhancing mRNA nanocarrier performance.
Simplified